SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Update on Nasdaq Matters BEIJING,

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-30
Original SEC Filing: Click here


Webplus: SVA/20171130/6-K/2_EX-99.1/000.htm SEC Original: tv480520_ex99-1.htm
Sinovac Biotech Announces Update on Nasdaq Matters BEIJING, November 30, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request to extend the stay of suspension in trading of the Company’s common shares pending a hearing on January




Webplus: SVA/20171130/6-K/1/000.htm SEC Original: tv480520_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085

Home Page Forums

By | 2017-11-30T15:32:28+00:00 November 30th, 2017|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar